Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy: boon or bane?

H R Shibata1

  • 1Department of Surgery, McGill University, Royal Victoria Hospital, Montreal, Que.

Canadian Journal of Surgery. Journal Canadien De Chirurgie
|October 1, 1995
PubMed
Summary

Breast cancer incidence is rising, particularly in older women. Hormone replacement therapy (HRT) use should be individualized after patient consultation, considering potential estrogen links to breast cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Randomized trial of 3-hour versus 24-hour infusion of high-dose paclitaxel in patients with metastatic or locally advanced breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
Same author

Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.

Biochimica et biophysica acta·1997
Same author

Small-bowel resection for metastatic melanoma.

Canadian journal of surgery. Journal canadien de chirurgie·1996
Same author

Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

The Journal of clinical investigation·1995
Same author

HIV-1 associated Kaposi's sarcoma in an African population.

The Canadian journal of oncology·1994

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Endocrinology

Background:

  • Breast cancer incidence is increasing, especially in elderly women.
  • Factors contributing to this rise include natural aging, earlier detection via mammography, and hormone replacement therapy (HRT) use.
  • Estrogen's correlation with breast cancer is well-established, alongside other risk factors like early menarche and obesity.

Purpose of the Study:

  • To highlight the need for careful consideration of hormone replacement therapy (HRT) in postmenopausal women.
  • To emphasize the importance of individualized treatment decisions for HRT.
  • To address the lack of robust clinical trial data for HRT's preventative efficacy.

Main Methods:

  • Review of existing literature on breast cancer risk factors and hormone replacement therapy (HRT).
  • Analysis of epidemiological trends in breast cancer incidence among elderly women.
  • Discussion of the scientific evidence linking estrogen to breast cancer development.

Main Results:

  • Hormone replacement therapy (HRT) is associated with an increased likelihood of breast cancer.
  • Early menarche, late menopause, obesity, and dietary factors are linked to higher breast cancer risk.
  • The efficacy of HRT for preventing osteoporosis and coronary artery disease lacks comprehensive scientific validation.

Conclusions:

  • Hormone replacement therapy (HRT) decisions must be individualized, requiring informed patient consent.
  • The potential risks, including breast cancer, should be weighed against unproven preventative benefits.
  • Further research is needed to establish the long-term safety and efficacy of HRT.

Related Experiment Videos